Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652844 · ClinicalTrials.gov registry record · NA
Use of AAM for Correction of Age Related Volume Deficits in the Face
A NA study, sponsored by Musculoskeletal Transplant Foundation.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03652844 is a NA study that has completed, run by Musculoskeletal Transplant Foundation. The registered enrollment target is 24 participants.
The verdict
NCT03652844, a NA study, has completed, sponsored by Musculoskeletal Transplant Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. The research will tell whether AAM is effective in maintaining mid-face fullness and whether the appearance of the skin improves after injection.
Interventions
- PROCEDURE AAM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2019-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03652844
The ClinicalTrials.gov registry entry for NCT03652844 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Musculoskeletal Transplant Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AAM is the first listed.
NCT03652844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03652844 about?
NCT03652844 is a clinical study titled "Use of AAM for Correction of Age Related Volume Deficits in the Face". The purpose of this study is to evaluate Allograft Adipose Matrix (AAM) in the face of people with age-related volume deficit - fat loss. AAM is a tissue used to correct fat loss. Participation in this study requires injections for placing AAM in the bilateral pre-jowl and malar areas of the face. T...
What is the current status of trial NCT03652844?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-08-27. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT03652844?
The interventions under investigation include: AAM (PROCEDURE).
Who is sponsoring clinical trial NCT03652844?
This trial is sponsored by Musculoskeletal Transplant Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.